Standard of care
OtherStandard medical treatment of ADHF patients deemed to have insufficient diuretic response.
NCT Number: NCT04877652
The study objective is to observe and measure clinical outcomes, urine output, and safety events occurring during standard medical treatment of ADHF patients deemed to have insufficient diuretic response.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
Columbia University Irving Medical Center, New York, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard medical treatment of ADHF patients deemed to have insufficient diuretic response.
Time frame: 30 days
SAEs (including MACE) post enrollment based on CEC adjudication.
Time frame: Baseline [T=0] and 48 hours
Change in level
Time frame: Baseline [T=0-12h] and through 24 hours [T=12-36h]
Change in the rate
Time frame: Baseline [T=0] and 48 hours
Change in dyspnea score using the Likert scale (score ranges from -3 to +3, higher score means better improvement)
Time frame: Baseline [T=0] and 48 hours
Change in score (ranges from none/0 to +4)
Time frame: through follow-up period completion (up to 60 days)
Length of current hospitalization (resolution of acute heart failure condition)
Time frame: Baseline through 30 days
Time to readmission due to HF, up to 30 days
Revamp Medical Ltd.
Industry
DR REGISTRY: Prospective Observational Study of Decongestion in Acute Heart Failure Patients With Insufficient Response to Diuretics
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06459115
Acute Decompensated Heart Failure, Disease Attributes
Homburg, Germany
View Trial DetailsNCT06453577
Acute Decompensated Heart Failure
Homburg, Germany
View Trial DetailsNCT05174312
Acute Decompensated Heart Failure
Fairhope, Alabama, United States
View Trial DetailsNCT06243029
Acute Decompensated Heart Failure, Cardiovascular Diseases
Cambridge, United Kingdom
View Trial Details